United Therapeutics (NASDAQ: UTHR) CEO sells 9,500 shares in preset plan
Rhea-AI Filing Summary
UNITED THERAPEUTICS Corp (UTHR) reported that family trusts associated with Chairperson & CEO Martine A. Rothblatt exercised 9,500 stock options at an exercise price of $135.42 per share into common stock and sold 9,500 common shares on August 24, 2026 in multiple trades at weighted-average prices around $509–$513 per share. The options transaction reduced the trust’s stock option position to 75,410 options. These transactions were carried out under a pre-arranged Rule 10b5-1 trading plan adopted on November 7, 2025, which continues until the earlier of the exercise of 1,734,410 options expiring March 15, 2027 or December 31, 2026. Separately, Rothblatt reports 40,513 UTHR common shares held directly and 166 shares held indirectly by spouse.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Exercise and Sale: 9,500 shares ($3.58M approx. pre-tax spread)
Exercise and Sale
12 txns
Insider
ROTHBLATT MARTINE A
Role
Chairperson & CEO
Sold
9,500 shs ($4.86M)
Approx. gross sale proceeds
$4.86M
Approx. exercise cost
$1.29M
Approx. pre-tax spread
$3.58M
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option F1, F11 | 9,500 | $0.00 | $0.00 |
| Exercise | Common Stock F1, F2 | 9,500 | $135.42 | $1.29M |
| Sale | Common Stock F1, F3, F2 | 224 | $509.4117 | $114K |
| Sale | Common Stock F1, F4, F2 | 1,323 | $510.5221 | $675K |
| Sale | Common Stock F1, F5, F2 | 3,056 | $511.6289 | $1.56M |
| Sale | Common Stock F1, F6, F2 | 3,592 | $512.4562 | $1.84M |
| Sale | Common Stock F1, F7, F2 | 1,305 | $513.3491 | $670K |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock F8 | -- | -- | -- |
| holding | Common Stock F9 | -- | -- | -- |
| holding | Common Stock F10 | -- | -- | -- |
Holdings After Transaction:
Stock Option — 75,410 shares (Indirect, by Trust);
Common Stock — 628,049 shares (Indirect, by Trust);
Common Stock — 40,513 shares (Direct);
Common Stock — 166 shares (Indirect, by Spouse)
Footnotes (11)
- F1. This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026.
- F10. Shares held in family trusts as to which the Reporting Person is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
- F11. Stock options held in a family trust as to which the Reporting Person shares investment power and the Reporting Person and immediate family members are beneficiaries.
- F2. Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
- F3. This transaction was executed in multiple trades at prices ranging from $508.76 to $509.75. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4. This transaction was executed in multiple trades at prices ranging from $510.00 to $510.98. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F5. This transaction was executed in multiple trades at prices ranging from $511.01 to $512.00. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F6. This transaction was executed in multiple trades at prices ranging from $512.03 to $513.01. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F7. This transaction was executed in multiple trades at prices ranging from $513.04 to $513.85. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F8. Shares held in family trusts as to which the Reporting Person's spouse is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
- F9. Shares held in family trusts as to which the Reporting Person's spouse shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
Key Figures
Stock options exercised: 9,500 options
Exercise price: $135.42 per share
Common shares sold: 9,500 shares
+5 more
8 metrics
Stock options exercised
9,500 options
Options exercised into common stock on August 24, 2026
Exercise price
$135.42 per share
Exercise price of stock options exercised on August 24, 2026
Common shares sold
9,500 shares
Total UTHR common shares sold by family trusts on August 24, 2026
Sale prices
$509.4117–$513.3491 per share
Weighted-average prices for the disclosed sale tranches on August 24, 2026
Options remaining in trust
75,410 options
Stock options remaining after the 9,500-option exercise in the reporting trust
Direct common stock holdings
40,513 shares
Common shares held directly by Martine A. Rothblatt after the reported transactions
Spouse common stock holdings
166 shares
Common shares held indirectly by spouse as reported on the Form 4
Options subject to trading plan
1,734,410 options
Maximum number of stock options referenced in the Rule 10b5-1 plan, expiring March 15, 2027
Key Terms
Rule 10b5-1 trading plan, weighted average price, family trusts, exercise of stock options, +1 more
5 terms
Rule 10b5-1 trading plan regulatory
"exercise of stock options and sale ... was pursuant to a pre-arranged 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"The price reported above reflects the weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
family trusts financial
"Shares held in family trusts as to which the Reporting Person shares investment power"
exercise of stock options financial
"This exercise of stock options and sale of the resulting shares of common stock"
FAQ
What insider transactions did UTHR CEO Martine A. Rothblatt report on August 24, 2026?
Family trusts associated with Martine A. Rothblatt exercised 9,500 stock options at $135.42 per share into common stock and sold 9,500 common shares in multiple trades at weighted-average prices between about $509 and $513 per share on August 24, 2026.
Were the August 24, 2026 UTHR insider transactions done under a Rule 10b5-1 plan?
Yes. The option exercise and related common stock sales were carried out under a pre-arranged Rule 10b5-1 trading plan adopted by Martine A. Rothblatt on November 7, 2025. The plan continues until the earlier of exercising 1,734,410 options or December 31, 2026.
How many United Therapeutics (UTHR) stock options did the reporting trusts exercise and what remains?
The family trusts exercised 9,500 stock options at an exercise price of $135.42 per share. After this exercise, 75,410 stock options linked to those trusts remain outstanding, all expiring on March 15, 2027.
How are the UTHR securities involved in this Form 4 held in relation to Martine A. Rothblatt?
Common stock and options are held largely through family trusts where Martine A. Rothblatt is sole trustee and beneficiary, or shares investment power with family members. Some shares are held in trusts where the spouse is trustee, and 166 shares are reported as held by spouse.
AI-generated analysis. How Rhea-AI works. Not financial advice.
